Study Stopped
insufficient enrollment
In Vivo Raman Spectroscopy of Human Capillary Beds
IVRS
In Vivo Raman Spectroscopy (IVRS) of Human Fingertip Capillary Beds
1 other identifier
observational
5
1 country
1
Brief Summary
The LighTouch device shines imperceptible red light into the skin and measures the light that comes back out using the method of Raman Spectroscopy. Some of this light is color shifted and some is not. Using a proprietary numerical recipe, the LighTouch device combines the signals in this remitted light and calculates hematocrit, glucose, protein and potentially other analytes. Thus the LighTouch device produces information without painful physical insult to the patient and can trend changes in these blood analytes in order to predict the need for intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 25, 2014
CompletedFirst Posted
Study publicly available on registry
January 7, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedApril 18, 2024
April 1, 2024
11.4 years
November 25, 2014
April 16, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
correlation with actual measured hematocrit
2 hours during dialysis
Study Arms (1)
IVRS studied
subjects will be monitored for changes in hematocrit based on results of in vivo raman spectroscopy scatter
Interventions
near infrared light will be shone upon a fingerbed capillary and light scatter measured using in vivo raman spectroscpy
Eligibility Criteria
stabel dialysis patients
You may qualify if:
- adult stable on dialysis and able to consent
You may not qualify if:
- inability to acquire IVRS signal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Dialsyis Center
Syracuse, New York, 13210, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph Chaiken, PhD
Syracuse University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 25, 2014
First Posted
January 7, 2015
Study Start
August 1, 2012
Primary Completion
January 1, 2024
Study Completion
January 1, 2024
Last Updated
April 18, 2024
Record last verified: 2024-04